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Abstract
Background: Interpreting the erythroid lineage in populations with high frequency of a+ thalassemia allele is
challenging due to the high prevalence of a+ thalassemia homozygotes. For such populations, separate reference
values for normal and a+ thalassemia homozygotes are needed.
Methods: We studied the erythroid lineage in 1,079 citizens of United Arab Emirates (UAE). Subjects with abnormal
hemoglobin (39), iron deficiency (136) or erroneous entries (8) were excluded. MCV distribution in the remaining
individuals (896) was visibly bimodal. Statistical mixture analysis with Normix program was used to separate
subpopulations with normal and small red cells. Hardy-Weinberg equation was used to estimate genotype
frequencies.
Results: MCV of 78.0 fl separated phenotype-derived normal homozygotes (715) from phenotype-derived a+
thalassemia homozygotes (181). The erythrocyte indices were significantly different between the two groups (p <
0.0001). The overall prevalence of phenotype-derived a+ thalassemia homozygotes (-a/-a) was 0.20 and markedly
varied among tribes, 0 to 0.31 (Mean = 0.15). The frequency of phenotype-derived a+ thalassemia allele was 0.44;
when accounting for tribal population structure and inbreeding, the calculated frequency was 0.34. These values
were very similar to those found in the same population by genotyping and other phenotyping methods. The
erythrocyte reference values for phenotype-derived normal homozygotes in Emiratis closely overlapped with those
for Caucasians and normal homozygotes defined by genotyping. The reference values for phenotype-derived a+
thalassemia homozygotes in Emiratis also closely overlapped with those for a+ thalassemia homozygotes defined
by genotyping.
Conclusion: In populations with frequent a+ thalassemia mutations, two sets of erythrocyte reference values could
be determined without genotyping.
Background
The prevalence of a+ thalassemia allele in Peninsular
Arabs varies between 0.07 and 0.58 [1-5]. In UAE
nationals, the frequency of a+ thalassemia allele is
reported to be between 0.30 and 0.37 [1,2]. In these
populations, the most common mutations are deletional,
involving one of the linked pair of a-globin genes. Con-
sequently, the genotypes are heterozygous a+ thalasse-
mia (-a/aa), homozygous a+ thalassemia (-a/-a) and
normal genotype (aa/aa). In contrast, deletional muta-
tions of both paired genes (-/aa), ao thalassemia, are
absent in Gulf Arabs [1,6].
Most a-globin gene mutations decrease the size of red
cells and alter other indices [6-9]. a+ Thalassemia homo-
zygote is characterized by lower hemoglobin (Hb), lower
mean corpuscular volume (MCV), lower mean corpuscu-
lar hemoglobin (MCH) and higher red blood cell (RBC)
count. a+ Thalassemia heterozygotes have red cell indices
that are between the normal genotype and a+ thalassemia
homozygotes [7,8]. A high frequency of a+ thalassemia
allele in a population often causes microcytosis and misin-
terpretation of the blood counts. This frequently leads to
unnecessary testing and increases health costs. Addition-
ally, in such populations the mean values of red cell
indices are expected to be decreased and the standard
deviations to be increased, as is also apparent from the
reference intervals of red cells indices in two such popula-
tions [10,11]. Therefore, it is inappropriate for populations
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with high frequency of a+ thalassemia allele to use the
“Western” erythroid standards, developed for people with
little a+ thalassemia. In populations with high frequency
of a+ thalassemia allele, the use of separate reference
values for normal and a+ thalassemia homozygotes, simi-
lar to those in use for different genders and age groups, is
more appropriate.
The erythroid standards for populations with high fre-
quency of a+ thalassemia are best defined with genotyp-
ing [8]. However, for most of them this is expensive and
technically challenging. Nonetheless, the same goal may
well be achieved with a combination of red cell pheno-
typing and mixture analysis. The resulting reference
values, if properly validated, are still more appropriate
than currently used standards derived for genetically dif-
ferent populations. This study is conducted to establish
red cell reference standards for Emirati population by
phenotyping and to validate them through comparison
with the results of other studies.
Methods
Setting and study population
Details on study subjects have been reported previously
[12]. Briefly, data were collected from 1,079 native UAE
citizens, ethnically Arab, 538 females, 539 males
and two of unknown gender. The age (mean ± SD) was
24.3 ± 6.3 years (range, 11 - 69); only 5 individuals were
younger than 15 years.
The UAE population is tribal (67 tribes as per the
1968 census) and endogamous, and has high frequencies
of a- and b-globin gene mutations [1,2,13]. Consangui-
neous marriages, which increase the likelihood of homo-
zygosis, are common [14]. The government mandates
and fully funds a premarital screening program for UAE
citizens. The main purpose of the program is to
decrease the incidence of b-thalassemia and sickle cell
disease and marriages are not officially recognized with-
out screening. All study subjects were participants of
this program between March and August 2007.
Study variables
Blood was collected in EDTA-tubes. Complete blood
counts were performed once on each subject, using the
Cell-Dyn Sapphire (Abbot Diagnostics, USA) analyzer.
The hospital laboratory subscribed to external quality
control conducted by United Kingdom National Exter-
nal Quality Assessment Scheme and met the analytic
standards. Hemoglobin analysis was performed using
high-pressure liquid chromatography (Variant II, Biorad
Co.). Genotyping was not performed in this program.
Selection criteria
Subjects (39) with abnormal hemoglobin (hemoglobin
A2 > 3.5% or presence of hemoglobin S, D or E) were
excluded from analysis. As iron deficiency was relatively
common among UAE females and iron measurements
were not routinely performed in this program, RDW ≥
14.0 was used to exclude subjects (136) with iron defi-
ciency. This cutoff was the upper limit (mean+2SD) for
our male subjects (see Results). In the absence of iron
deficiency, MCV differences between males and females
were not statistically significantly different, corroborat-
ing the assumption of equivalency of their red cell sizes
[7,8,15].
Analytics
Erroneous or missing data were excluded: 13 RDW, five
RBC counts, two MCV, six MCH and one hemoglobin
A2. The study subjects were grouped and compared by
gender and tribe, as identified by their last name. Stan-
dard descriptive and analytic statistical methods, such as
histograms, linear regression and independent samples
t-test were used.
As the distribution of MCV was visibly bimodal, a sta-
tistical mixture analysis was performed using PC-Nor-
mix program http://www.alumni.caltech.edu/~wolfe/
normix.htm [16]. This analysis can identify two or more
clusters with normal (Gaussian) distributions within a
mixed population. In this study, the distribution of
MCV appeared to comprise only two clusters (Figure 1).
Further analysis of red cell parameters in the two popu-
lations (clusters) was performed using SPSS for Win-
dows, Version 17.1. The allele frequency was derived
from the frequency of low-MCV phenotype which was
assumed to represent a+ thalassemia homozygote. These
calculations were performed for whole population and
Figure 1 Frequency distribution of MCV.
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for each of the ten tribes. The phenotype-derived geno-
type frequencies were then calculated using Hardy-
Weinberg formula corrected for inbreeding,. viz. for a+
thalassemia homozygotes q2(1 - F) + qF, for a+ thalasse-
mia heterozygotes 2pq(1 - F) and normal homozygotes
p2(1 - F) + pF [17]. The mean coefficient of inbreeding
(F) in this population was previously found to be 0.022
(14), which we assumed to apply. The level of signifi-
cance was set at <0.05.
Ethical approval
The study was approved by Al Ain Medical District
Human Research Ethics Committee.
Results
The erythrocyte indices of 1,040 subjects without hemo-
globinopathies other than a+ thalassemia are shown in
Table 1A. Subjects with RDW ≥14.0% were presumed to
have iron deficiency (Table 2) and were excluded from
estimating the reference intervals; an additional 8 sub-
jects with incomplete data were also excluded. Their
exclusion however only changed the values in the
females (Table 1B). The frequency distribution of MCV
in the remaining 896 subjects (Table 1B) showed two
distinct subpopulations, but bimodal distribution of
MCH was less distinct (Figure 1 and 2); the distributions
of hemoglobin and hematocrit were apparently homoge-
nous. Thus MCV was chosen to separate phenotypically
normal from small red cells.
Mixture analysis of MCV of 896 subjects found78.0 fl
to best separate phenotypically normal from small red
cells in the sense that the estimated probability of being
phenotypically normal exceeded 0.50 for values ≥78 fl.
Using a P-P (probability) plot, the empirical cumulative
probability distribution of our MCV data plotted against
that obtained by mixture analysis yielded an almost per-
fect straight, diagonal, line, suggesting an excellent fit.
Consequently, reference intervals for subjects with nor-
mal phenotypes and a+ thalassemia homozygous pheno-
type were based on the estimated means and standard
deviations of the two constituent normal distributions of
the mixture distribution and are shown in Table 3.
When we treated the population as homogeneous, the
estimated prevalence of phenotype-derived a+ thalasse-
mia homozygotes (181 of 896) was 0.20 and the
prevalences of phenotype-derived a+ thalassemia hetero-
zygotes and normal homozygotes were 0.49 and 0.31,
respectively; the estimated frequency of phenotype-
derived a+ thalassemia allele was 0.44. However, the
prevalence of phenotype-derived a+ thalassemia homo-
zygotes varied substantially among the ten largest tribes
(mean = 0.15), potentially vitiating the assumption of a
single homogeneous population (Figure 3). Using strati-
fication by tribe, the prevalence of phenotype-derived a+
thalassemia heterozygotes was 0.45 and that of normal
phenotype 0.40. Phenotype-derived a+ thalassemia allele
frequency in each tribe was adjusted for inbreeding and
found to vary from 0 to 0.55. The aggregate frequency
of the allele adjusted for population structure and
inbreeding was 0.34.
Discussion
The red cell reference intervals for male and female
Emiratis are noticeably broader (Table 1) than in other
Caucasian populations in which a+ thalassemia is rare
[15]. Similar observations were reported on young adults
Table 1 Erythrocyte indices in the study subjects (Aa) and in those with RDW <14.0% (Bb)
RBC(×106/μL) Hb (g/dL) Hct (%) MCV (fL) MCH (pg) MCHC(%) RDW (%)
Mean Mean Mean Mean Mean Mean Mean
N ± 2SD ± 2SD ± 2SD ± 2SD ± 2SD ± 2SD ± 2SD
A All 1,040 5.3 14 42.9 82.1 26.8 32.6 12.6
4.0-6.5 10.5-17.5 33.2-52.7 66.6-97.6 20.6-33.0 30.4-34.8 9.2-15.9
M 520 5.6 15.3 46.5 83.6 27.5 32.8 12.1
4.5-6.7 13.0-17.6 40.5-53.0 70.1-97.1 22.0-33.0 30.7-35.0 10.3-13.9
F 520 4.9 12.8 39.4 80.6 26.1 32.4 13.1
4.0-5.9 10.2-15.4 32.5-46.2 63.8-97.3 19.5-32.7 30.2-34.6 9.0-17.2
B All 896 5.3 14.4 43.8 83.4 27.3 32.3 12.1
4.1-6.5 11.4-17.3 35.4-52.2 70.2-96.7 22.0-32.7 30.7-34.8 10.5-13.7
M 495 5.6 15.3 46.6 83.8 27.6 32.8 12.0
4.5-6.7 13.1-17.4 40.4-52.8 70.2-96.7 22.2-32.9 30.7-35.0 10.6-13.4
F 401 4.9 13.2 40.4 82.9 27.1 32.6 12.2
4.0-5.8 11.3-15.1 35.2-45.6 69.6-96.3 21.7-32.5 30.7-34.6 10.5-14.0
aSubjects with abnormal hemoglobin electrophoresis (n = 39) were excluded.
bSubjects with RDW >14.0% (n = 136, Table 2) were presumed to have iron deficiency and were excluded from estimating the reference intervals. Erroneous or
incomplete data (n = 8) were also exclude from estimating the reference intervals.
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in Saudi Arabia, in whom the frequency of a+ thalasse-
mia allele varies between 0.07 and 0.5, as well as in
Palestinians [10,11]. This finding is expected in any
population with considerable variations in the number
and size of red cells, i.e., a+ thalassemia heterozygotes
and homozygotes and normal homozygotes. In general,
the effect of a+ thalassemia allele frequency on the three
genotypes and their aggregate effects on the mean
values of red cell parameters are shown in Figure 4.
This analysis shows that the standards developed in
populations with frequent a+ thalassemia are shifted to
one side and wider, less precise, and critically depend
on the frequency of a+ thalassemia allele. Therefore,
such populations require separate reference intervals,
one for subjects with phenotypically normal red cells
and another for those with small red cells.
We separated two cell populations based on their size
(MCV) rather than MCH, despite earlier reports that
MCH is more useful in separating a+ thalassemia homo-
zygotes from normal homozygotes [8]. The main reason
for preferring MCV over MCH was that in our sample
the frequency distribution of MCV was more clearly
bimodal than that of MCH (Figures 1 and 2). As we
were using mixture analysis (which breaks down a
population into its constituent subpopulations by
decomposing a frequency distribution into a mix of two
normal distributions; here belonging to the normal and
a+ thalassemia homozygote phenotype subpopulations,
respectively), MCV rather than MCH appeared a better
parameter to accomplish this task. In the study that
found MCH a more useful than MCV in separating nor-
mal from a+ thalassemia homozygotes, the subjects’
genotypes were known and a+ thalassemia heterozygotes
were excluded from analysis [8], which we could not do.
Nonetheless, the distributions of normal and small red
cell populations clearly overlap (Figure 1). In our study,
a value of 78.0 fl seems to best separate subjects with
normal red cells from those with small red cells. The
validity of this finding is supported by the finding in
another study in which the same value of MCV best
predicted a+ thalassemia homozygote defined by geno-
typing [18].
When tribal population stratification was taken into
account (Figure 3) and adjusted for inbreeding, pheno-
type-derived a+ thalassemia allele frequency was esti-
mated at 0.34, and. the prevalence of phenotype-derived
a+ thalassemia homozygotes at 0.12. These results are
similar to reports of homozygote frequencies obtained
using genotyping (0.11) and other phenotyping (0.14)
methods on the same population [1,2]. Heterogeneity in
allele frequency among tribes may well be due to foun-
der effects, with random numbers of a+ thalassemia
alleles segregated into subpopulations at the time of the
foundation of current tribes. These differences were pre-
served by the practice of endogamy, which limits gene
exchanges between the tribes. This substructure in the
Emirati population (the consequence of tribal history) is
also present in other Gulf Arab societies, and may
explain reported variations in a+ thalassemia frequency
among different Arab populations.
Remarkably, nearly half of the studied population is
deduced to be a+ thalassemia heterozygous. Although in
Table 2 Erythrocyte indices of subjects with RDW > 14.0%
RBC(×106/μL) Hb (g/dL) Hct (%) MCV (fL) MCH (pg) MCHC(%) RDW (%)
Mean Mean Mean Mean Mean Mean Mean
N ± 2SD ± 2SD ± 2SD ± 2SD ± 2SD ± 2SD ± 2SD
All 136 5.1 11.6 36.7 72.1 22.8 31.5 16.1
3.8-6.4 8.1-15.0 26.9-46.5 57.1-87.0 16.9-28.7 29.2-33.9 11.7-20.4
M 14 5.9 14.0 44.2 75.2 23.8 31.6 15.2
4.1-7.8 9.1-18.9 30.4-58.1 59.0-91.4 17.7-29.9 29.3-33.9 12.4-18.0
F 122 5.0 11.3 35.7 71.7 22.6 31.5 16.2
4.0-6.0 8.6-13.9 28.5-43.0 57.0-86.3 16.8-28.5 29.1-33.9 11.7-20.6
Figure 2 Frequency distribution of MCH.
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clinical practice these individuals are indistinguishable
from normal, their erythroid indices are between the
normal and a+ thalassemia homozygotes [7,8]. Yet, con-
trary to expectations, the high prevalence of these phe-
notype-derived heterozygotes did not “blur” the
bimodality of the distribution of MCV (Figure 1), sug-
gesting that MCV values of most phenotype-derived a+
thalassemia heterozygotes are well within the normal
range. Indeed, in another study of red cell sizes in
known genotypes, 64% of the a+ thalassemia heterozy-
gotes had MCV >78.0 fl [18].
As expected, the erythroid parameters for phenotype-
derived normal and phenotype-derived a+ thalassemia
homozygotes are significantly different (Table 3). For
phenotypically normal subjects, the reference intervals
closely overlap with those for Caucasians in which a+
thalassemia homozygosis is rare (Figure 5) [19-24].
Additionally, reference intervals markedly or completely
overlap with the intervals published for adults genotyped
as aa/aa (Figure 6) [7]. The results show that phenoty-
pically normal Arabs have the same erythroid para-
meters as people of European origin. For phenotype-
derived a+ thalassemia homozygotes, the reference
intervals overlap with those for adults with -a/-a geno-
type (Figure 7) [7]. These comparisons validate our
results obtained with phenotyping and mixture analysis
of phenotypes. The observed variations of reference
intervals in Figures 5, 6, 7 and in other studies would
seem attributable to sample size, subject selection, and
sample handling and processing.
A possibly contentious issue is the use of RDW
≥14.0% to identify iron deficiency. This unsatisfactory
test may have introduced errors in estimating the preva-
lence of phenotype-derived a+ thalassemia homozygotes.
This bias however is likely to be small, as nine times
more women than men are excluded (Table 2), and the
prevalence of phenotype-derived a+ thalassemia homo-
zygotes in two genders is not significantly different (p =
0.34). In general, in the absence of significant iron defi-
ciency, which is more prevalent in women than in men,
there is no evidence that MCV of men and women are
different. Thus, the use of the upper limit of normal
RDW in males (Table 1A) to exclude iron deficiency in
the females seems reasonable. A similar value for the
upper limit of normality of RDW is found in Caucasian
males of comparable age [15].
Table 3 Erythrocyte indices in subjects with normal (A) and small (B) red cellsa
RBC(×106/μL) Hb (g/dL) Hct (%) MCV (fL) MCH (pg) MCHC(%) RDW (%)
Mean Mean Mean Mean Mean Mean Mean
N ± 2SD ± 2SD ± 2SD ± 2SD ± 2SD ± 2SD ± 2SD
A All 715 5.1 14.5 44.1 86.1 28.4 33.0 11.9
4.1-6.2 11.7-17.4 35.9-52.3 77.5-94.6 24.7-32.1 31.1-34.9 10.5-13.3
M 398 5.4 15.4 46.8 86.4 28.6 33.1 11.8
4.5-6.3 13.4-17.5 40.5-53.0 78.2-95.6 25.1-32.1 31.1-35.0 10.6-13.0
F 317 4.8 13.4 40.8 85.6 28.1 32.9 12.0
4.1-5.5 11.7-15.1 35.9-45.7 76.6-94.6 24.3-31.9 31.1-34.6 10.4-13.7
B All 181 5.9* 13.6* 42.6* 73.0* 23.2* 31.9* 12.8*
4.6-7.1 10.7-16.4 33.8-51.4 67.2-78.7 20.8-25.7 30.2-33.5 11.4-14.1
M 97 6.3 14.6 45.8 73.1 23.3 31.9 12.7
5.4-7.1 12.8-16.4 40.1-51.6 67.2-79.0 20.9-25.7 30.2-33.5 11.4-14.1
F 84 5.4 12.4 39.0 72.8 23.2 31.8 12.9
4.5-6.2 10.6-14.2 33.7-44.2 67.1-78.4 20.6-25.7 30.2-33.4 11.6-14.3
aMCV = 78.0 fl used as a separating value.
* P < 0.0001.
Figure 3 Prevalence of phenotype-derived a+ thalassemia
homozygotes in ten largest tribes.
Denic et al. BMC Blood Disorders 2011, 11:1
http://www.biomedcentral.com/1471-2326/11/1
Page 5 of 8
Figure 4 Mean Hb, MCV and RBC values (thick lines) at different a+ thalassemia allele frequencies. Genotype frequencies (thin lines) are
of aa/aa (normal homozygote), -a/aa (a+ thalassemia heterozygote) and -a/-a (a+ thalassemia homozygote). Data were created using Hardy-
Weinberg equation and published values for the three genotypes [8,18].
Figure 5 Erythrocyte reference intervals for phenotypically normal Emiratis (thick lines, data from Table 3A) and Caucasians (thin
lines). The RBC and Hb values are in males and the MCV and MCH values are in both genders. The numbers indicate references.
Figure 6 Erythrocyte reference intervals for phenotypically normal Emiratis (thick lines, data from Table 3A) and Spanish population
with aa/aa genotype (thin lines, data from Reference [7]).
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Conclusion
For clinical purposes, two sets of erythroid intervals
are needed for populations with a high frequency of a+
thalassemia allele. This study is the first to propose
such reference intervals for clinical use, one for a
population with normal and another for a population
with small red cells (Table 3). The studied population
is heterogeneous as regards the a+ thalassemia allele, a
heterogeneity that differs by tribal alliance. This study
demonstrates a new approach for the development of
red cell reference standards through a combination of
phenotyping and mixture analysis. The reference inter-
val it produced appear to be consistent with those
obtained by genotyping. In addition, a+ thalassemia
allele frequency estimates using this method are similar
to those obtained by genotyping. Thus both results
support the validity of this approach. Our results are
applicable to other Gulf Arabs of the same origin, i.e.
old Bedouin. Also, our methods can easily be utilized
in other populations with a high frequency of a+ tha-
lassemia homozygotes in which genotyping is not feasi-
ble or affordable.
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